Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shomik Sengupta

Showing results (111-120 of 166) with videos related to

Pageof 17
Sort By:
BJU International|April 24, 2019
Metformin may offer no protective effect in men undergoing external beam radiation therapy for prostate cancerWeranja K B Ranasinghe, Scott Williams, Joseph Ischia, et al.
Urology|March 1, 2008
Association of abnormal preoperative laboratory values with survival after radical nephrectomy for clinically confined clear cell renal cell carcinomaJames S Magera, Bradley C Leibovich, Christine M Lohse, et al.
Cancers|June 10, 2022
PSMA PET-CT Imaging Predicts Treatment Progression in Men with Biochemically Recurrent Prostate Cancer-A Prospective Study of Men with 3 Year Follow UpSean Ong, Claire Pascoe, Brian D Kelly, et al.
BJU International|September 9, 2014
The Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group--a new co-operative cancer trials group in genitourinary oncologyShomik Sengupta, Peter Grimison, Dickon Hayne, et al.
BJU International|January 5, 2008
After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancerShomik Sengupta, Michael L Blute, Stephanie M Bagniewski, et al.
Cancers|January 25, 2025
Symptoms and Side Effects of Bacille Calmette-Guerin Therapy for Non-Muscle Invasive Bladder Cancer as Reported by Patients: A Systematic ReviewJohn Lahoud, Alfin Okullo, Claudia Rutherford, et al.
Cancers|December 23, 2022
Distant Nodes Seen on PSMA PET-CT Staging Predicts Post-Treatment Progression in Men with Newly Diagnosed Prostate Cancer-A Prospective Cohort StudySean Ong, Claire Pascoe, Brian D Kelly, et al.
The Journal of Urology|February 14, 2006
Impact of patient age at treatment on outcome following radical retropubic prostatectomy for prostate cancerSameer A Siddiqui, Shomik Sengupta, Jeffrey M Slezak, et al.
The Journal of Urology|July 4, 2006
Detectable prostate specific antigen between 60 and 120 days following radical prostatectomy for prostate cancer: natural history and prognostic significanceShomik Sengupta, Carl M Christensen, Horst Zincke, et al.
Cancer|June 15, 2006
Obesity and survival after radical prostatectomy: A 10-year prospective cohort studySameer A Siddiqui, Brant A Inman, Shomik Sengupta, et al.
Pageof 17

Showing results (111-120 of 166) with videos related to

Sort By:
Pageof 17
BJU International|April 24, 2019
Metformin may offer no protective effect in men undergoing external beam radiation therapy for prostate cancerWeranja K B Ranasinghe, Scott Williams, Joseph Ischia, et al.
Urology|March 1, 2008
Association of abnormal preoperative laboratory values with survival after radical nephrectomy for clinically confined clear cell renal cell carcinomaJames S Magera, Bradley C Leibovich, Christine M Lohse, et al.
Cancers|June 10, 2022
PSMA PET-CT Imaging Predicts Treatment Progression in Men with Biochemically Recurrent Prostate Cancer-A Prospective Study of Men with 3 Year Follow UpSean Ong, Claire Pascoe, Brian D Kelly, et al.
BJU International|September 9, 2014
The Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group--a new co-operative cancer trials group in genitourinary oncologyShomik Sengupta, Peter Grimison, Dickon Hayne, et al.
BJU International|January 5, 2008
After radical retropubic prostatectomy 'insignificant' prostate cancer has a risk of progression similar to low-risk 'significant' cancerShomik Sengupta, Michael L Blute, Stephanie M Bagniewski, et al.
Cancers|January 25, 2025
Symptoms and Side Effects of Bacille Calmette-Guerin Therapy for Non-Muscle Invasive Bladder Cancer as Reported by Patients: A Systematic ReviewJohn Lahoud, Alfin Okullo, Claudia Rutherford, et al.
Cancers|December 23, 2022
Distant Nodes Seen on PSMA PET-CT Staging Predicts Post-Treatment Progression in Men with Newly Diagnosed Prostate Cancer-A Prospective Cohort StudySean Ong, Claire Pascoe, Brian D Kelly, et al.
The Journal of Urology|February 14, 2006
Impact of patient age at treatment on outcome following radical retropubic prostatectomy for prostate cancerSameer A Siddiqui, Shomik Sengupta, Jeffrey M Slezak, et al.
The Journal of Urology|July 4, 2006
Detectable prostate specific antigen between 60 and 120 days following radical prostatectomy for prostate cancer: natural history and prognostic significanceShomik Sengupta, Carl M Christensen, Horst Zincke, et al.
Cancer|June 15, 2006
Obesity and survival after radical prostatectomy: A 10-year prospective cohort studySameer A Siddiqui, Brant A Inman, Shomik Sengupta, et al.
Pageof 17